Literature DB >> 3733223

Effect of perorally administered lactobacilli on macrophage activation in mice.

G Perdigon, M E de Macias, S Alvarez, G Oliver, A A de Ruiz Holgado.   

Abstract

The effect of perorally (p.o) administered Lactobacillus casei and L. bulgaricus on macrophage activation in mice was studied. L. casei and L. bulgaricus were administered p.o. to mice for 8 days. The macrophage activation was measured on days 2, 3, 5, and 8 of lactobacillus administration by using biochemical and functional criteria. We measured the release of lysosomal hydrolases, the level of a nonlysosomal enzyme, and in vitro phagocytic activity of mouse peritoneal macrophages. All the assays were performed comparatively with mice inoculated with L. casei and L. bulgaricus (viable and nonviable cells) intraperitoneally (i.p.) at the same dose as for p.o. administration. The phagocytic activity was significantly higher in mice treated i.p. than in control mice. For p.o. administration, there was an increase only when L. casei was used. L. bulgaricus had little effect. No differences were found between viable and nonviable cells. The phagocytic function of the reticuloendothelial system was tested by the carbon clearance test, which showed that L. casei and L. bulgaricus accelerate the phagocytic function in mice treated p.o and i.p., from day 2 onward. These observations show that L. casei and L. bulgaricus given by p.o. administration are able to activate macrophages in mice and suggest that these bacteria, when passing through the intestinal tract, may be responsible for the enhanced host immune response. This fact is very significant because the diet includes fermented and manufactured products containing lactobacilli.

Entities:  

Mesh:

Year:  1986        PMID: 3733223      PMCID: PMC260890          DOI: 10.1128/iai.53.2.404-410.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Mammalian glycosidases; distribution in the body.

Authors:  J CONCHIE; J FINDLAY; G A LEVVY
Journal:  Biochem J       Date:  1959-02       Impact factor: 3.857

2.  Influence of viable yogurt microflora on digestion of lactose by the rat.

Authors:  E R Goodenough; D H Kleyn
Journal:  J Dairy Sci       Date:  1976-04       Impact factor: 4.034

3.  Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells.

Authors:  T T MacDonald; P B Carter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

4.  Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens.

Authors:  I Kato; T Yokokura; M Mutai
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

5.  Effect of oral administration of a variety of bacteria on depressed macrophage functions in tumour-bearing rats.

Authors:  D Iannello; L Bonina; D Delfino; M C Berlinghieri; M R Gismondo; P Mastroeni
Journal:  Ann Immunol (Paris)       Date:  1984 May-Jun

6.  Macrophage activation by Lactobacillus casei in mice.

Authors:  I Kato; T Yokokura; M Mutai
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

7.  Antitumor activity of Lactobacillus casei in mice.

Authors:  I Kato; S Kobayashi; T Yokokura; M Mutai
Journal:  Gan       Date:  1981-08

8.  Adjuvanticity of lactobacilli. I. Differential effects of viable and killed bacteria.

Authors:  N Bloksma; E de Heer; H van Dijk; J M Willers
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

9.  Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages.

Authors:  J Schnyder; M Baggiolini
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  The enhancing effect of the microbial flora on macrophage function and the immune response. A study in germfree mice.

Authors:  H Bauer; F Paronetto; W A Burns; A Einheber
Journal:  J Exp Med       Date:  1966-06-01       Impact factor: 14.307

View more
  31 in total

Review 1.  The scientific basis for probiotic strains of Lactobacillus.

Authors:  G Reid
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

Review 2.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

Review 3.  The influence of yogurt/Lactobacillus on the innate and acquired immune response.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

Review 4.  Pro and anti: the biotics of allergic disease.

Authors:  J Crane
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 5.  The protective potency of probiotic bacteria and their microbial products against enteric infections-review.

Authors:  J F J G Koninkx; J J Malago
Journal:  Folia Microbiol (Praha)       Date:  2008-07-27       Impact factor: 2.099

Review 6.  Probiotics in human medicine.

Authors:  R Fuller
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

7.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  West J Med       Date:  1999-09

8.  Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model.

Authors:  D Adawi; G Molin; B Jeppsson
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

9.  Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp.

Authors:  Angela J Henderson; Ajay Kumar; Brittany Barnett; Steven W Dow; Elizabeth P Ryan
Journal:  J Med Food       Date:  2012-01-16       Impact factor: 2.786

10.  The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity.

Authors:  F A Klaver; R van der Meer
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.